§ 13F · FUND PROFILE
Caligan Partners LP.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 28Turnover · — · Q1Filed · May 15, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$230M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 15, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | LQDA | LIQUIDIA CORPORATION | 8.12M | $306M | 20.4% | ±0% |
| 2 | ABVX | ABIVAX SA | 1.46M | $163M | 10.8% | +1% |
| 3 | RVMD | REVOLUTION MEDICINES INC | 1.65M | $161M | 10.7% | +47% |
| 4 | PCVX | VAXCYTE INC | 2.06M | $120M | 8.0% | +21% |
| 5 | XENE | XENON PHARMACEUTICALS INC | 1.39M | $81M | 5.4% | +27% |
| 6 | MLYS | MINERALYS THERAPEUTICS INC | 2.77M | $75M | 5.0% | −45% |
| 7 | EXEL | EXELIXIS INC | 1.55M | $67M | 4.4% | ±0% |
| 8 | CGON | CG ONCOLOGY INC | 900K | $61M | 4.1% | NEW |
| 9 | TNGX | TANGO THERAPEUTICS INC | 2.41M | $50M | 3.4% | −35% |
| 10 | TYRA | TYRA BIOSCIENCES INC | 1.28M | $49M | 3.3% | +35% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE CALIGAN SIGNAL
AC read
Caligan Partners LP is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed